Nemo Ikonen

18.6.2026

Päivämäärä
18.06.2026
Sijainti
Biomedicum Helsinki 1, luentosali 2
Organisaatio
Nemo Ikonen, University of Helsinki, Faculty of MedicinE, Doctoral Programme in Biomedicine
Yhteyshenkilö
nemo.ikonen@helsinki.fi

VÄITÖS: Nemo Ikonen, University of Helsinki, Faculty of MedicinE, Doctoral Programme in Biomedicine

Targeting epigenetic and metabolic vulnerabilities in high-risk acute myeloid leukemia and myelodysplastic syndromes

Opponent: Associate Professor Cristina Tognon, Knight Cancer Institute, Oregon Health & Science University